Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion type Assertion NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_head.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion description "[Imatinib mesylate (Gleevec), a small molecule inhibitor of abl, kit, and platelet-derived growth factor receptor (PDGFR) tyrosine kinases, has been reported to be effective in the treatment of hypereosinophilic syndrome (HES) and a rare eosinophilia-associated chronic myeloid disorder (eos-CMD) characterized by the t(5;12)(q33;p13) cytogenetic abnormality.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_provenance.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion evidence source_evidence_literature NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_provenance.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion SIO_000772 12506022 NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_provenance.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion wasDerivedFrom befree-20140225 NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_provenance.
- NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_assertion wasGeneratedBy ECO_0000203 NP480163.RAXgQnDWCs91UqKXcZoyEx-3evOC0VUu9yXGz0t4NZ31E130_provenance.